Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: Results from GPs ignoring guidelines and risk calculators

European Journal of General Practice

Volumn 13, Issue 1, 2007, Pages 27-34

  Oriol Zerbe, Christina ^a   Abholz, Heinz Harald ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cardiovascular diseases; General practice; Guidelines; Hyperlipidaemia; Primary prevention; Risk calculator

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; FACTORIAL ANALYSIS; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; GERMANY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HIGH RISK BEHAVIOR; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK ASSESSMENT; STRUCTURED INTERVIEW; ADULT; AGED; CLINICAL PRACTICE; DECISION MAKING; EUROPE; METHODOLOGY; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR; STANDARD; STATISTICS; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; DECISION MAKING; EUROPE; FAMILY PRACTICE; FEMALE; GERMANY; GUIDELINE ADHERENCE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRIMARY PREVENTION; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 34247843093     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.1080/13814780601050541     Document Type: Article

References (44)

1. Abholz, HH and Oriol, C. (2003) Coronary heart disease: Acceptance of guideline recommendations irrelevant in Germany?. Fam Pract, 20, p. 350.
2. Abookire, SA, Karson, AS, Fiskio, J. and Bates, DW. (2001) Use and monitoring of "statin" lipid-lowering drugs compared with guidelines. Arch Intern Med, 161, pp. 53-58.
3. Armstrong, D., Reyburn, H. and Jones, R. (1996) A study of general practitioners' reasons for changing their prescribing behaviour. Br Med J, 312, pp. 949-952.
4. Assmann, G., Cullen, P. and Schulte, H. (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation, 105, pp. 310-315.
5. Brindle, P., Emberson, J., Lampe, F., Walker, M., Whincup, P. and Fahey, T. (2003) Predictive accuracy of the Framingham coronary risk score in British men: Prospective cohort study. Br Med J, 327, pp. 1267-1270.
6. Britten, N., Stevenson, FA, Barry, CA, Barber, N. and Bradley, CP. (2000) Misunderstandings in prescribing decisions in general practice: qualitative study. Br Med J, 320, pp. 484-488.
7. Britten, N. and Ukoumunne, O. (1997) The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: A questionnaire survey. Br Med J, 315, pp. 1506-1510.
8. Cockburn, J. and Pit, S. (1997) Prescribing behaviour in clinical practice: Patients' expectations and doctors' perceptions of patients' expectations - a questionnaire study. Br Med J, 315, pp. 520-523.
9. Conroy, RM, Pyorala, K. and Fitzgerald, AP. (2003) Estimation of 10 yr risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J, 24, pp. 987-1003.
10. Cranney, M., Warren, E., Barton, S., Gardner, K. and Walley, T. (2001) Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract, 18, pp. 353-355.
11. De Backer, G., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R. and Dallongville, J. (2003) 171, pp. 141-155.
12. Durrington, PN. (1998) University of Manchester. Cardiac risk assessor program.
13. EUROASPIRE I and II Group (2001) Clinical reality of coronary prevention guidelines: A comparison of EUORASPIRE I and II Group. Lancet, 357, pp. 995-1001.
14. Fairhurst, K. and Huby, G. (1998) From trial data to practical knowledge: Qualitative study of how general practitioners have accessed and used evidence about statin drugs in their management of hypercholesterolaemia. Br Med J, 317, pp. 1130-1134.
15. Fisseni, G., Golücke, A. and Abholz, HH. (2003) Warum machen deutsche Allgemeinärzte so wenig Früherkennung?. Z Allg Med, 79, pp. 591-595.
16. Freeman, AC and Sweeney, K. (2001) Why general practitioners do not implement evidence: Qualitative study. Br Med J, 323, pp. 1-5.
17. Graham, RP, James, PA and Cowan, TM. (2000) Are clinical practice guidelines valid for primary care?. J Clin Epidemiol, 53, pp. 949-954.
18. Hayward, RSA, Guyatt, GH, Moore, KA, McKibbon, KA and Carter, AO. (1997) Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ, 156, pp. 1715-1723.
19. tool, HeartScore risk prediction
20. Hense, HW, Schulte, H., Löwel, H. and Gassmann, Keil U. (2003) Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and PROCAM cohorts. Eur Heart J, 24, pp. 937-945.
21. Hense, HW. (2003) Risk factor scoring for coronary heart disease. Br Med J, 327, pp. 1238-1239.
22. Hobbs, FD and Erhardt, L. (2002) Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: The Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract, 19, pp. 596-604.
23. Kedward, J. and Dakin, L. (2003) A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care. Br J Gen Pract, 53, pp. 684-689.
24. Keil, U., Fitzgerald, AP, Gohlke, H., Wellman, J. and Hense, H-W (2005) Risikoabschätzung tödlicher Herz-Kreislauf-Erkrankungen Dtsch Ärztebl, 102, pp. 1808-1812.
25. Galán, A Maiques and Canals, J. Vilaseca (2000) Variabilidad en la valoración del riesgo cardiovascular. Formación médica continuada (FMC), 7, pp. 611-628.
26. Mantel-Teeuwisse, AK, Verschuren, WM, Klungel, OH, Kromhout, D., Lindemans, AD and Avorn, J. (2003) Undertreatment of hypercholesterolaemia: A population-based study. Br J Clin Pharmacol, 55, pp. 389-397.
27. Marrugat, J., Solanas, P., D'Agostino, R., Sullivan, L., Ordovas, J., Cordón, F. and Ramos, R. (2003) Coronary risk estimation in Spain using a calibrated Framingham function. Revista Española de Cardiologia, 56, pp. 253-261.
28. McColl, A., Smith, H., White, P. and Field, J. (1998) General practitioners' perception of the route to evidence based medicine: A questionnaire survey. Br Med J, 316, pp. 361-365.
29. Group, National Cardiovascular Advisory The New Zealand Guidelines Group. New Zealand cardiovascular guide.
30. Health, National Institutes of, Lung, National Heart and Institute, Blood (2002) National Cholesterol Education Program III: Risk assessment tool.
31. Health, National Institutes of, Lung, National Heart and Institute, Blood (2001) Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).
32. Zerbe, C Oriol and Abholz, HH. (2004) Primärpräventive Verschreibung von Lipidsenkern in deutschen Hausarztpraxen-ein empirischer Vergleich zu den Vorgaben von Risikotabellen. Z Allg Med, 80, pp. 63-69.
33. Rice, PL and Ezzy, D. (1999) Qualitative research methods - a health focus, Oxford University Press, New York
34. Rose, G. (1992) The strategy of preventive medicine, Oxford University Press, New York
35. Savoie, I. and Kazanjian, A. (2002) Utilization of lipid-lowering drugs in men and women. A reflection of the research evidence?. J Clin Epidemiol, 55, pp. 95-101.
36. Network, Scottish Intercollegiate Guidelines (1999) Lipids and the primary prevention of coronary heart disease. A national clinical guideline. SIGN, SIGN, Edinburgh
37. Arnáiz, C Serna, Navarro, L Montull, Torguet, A Väzquez, Eguíluz, E Gascó, Luch, M Peremiquel and Barvo, M. Ortega (2000) Cuántos pacientes precisan tratamiento para la hipercolesteremia?. Atención Primaria, 25, pp. 395-399.
38. Stevenson, FA, Greenfield, SM, Jones, M., Nayak, A. and Bradley, CP. (1999) GPs' perceptions of patient influence on prescribing. Fam Pract, 16, pp. 255-261.
39. Tonstad, S., Rosvold, EO, Furu, K. and Skurtveit, S. (2004) Undertreatment and overtreatment with statins: The Oslo study 2000-2001. J Intern Med, 255, pp. 494-502.
40. Unwin, N., Thomson, R., O'Byrne, AM, Laker, M. and Armstrong, H. (1998) Implications of applying widely accepted cholesterol screening and management guidelines to a British adult population: Cross sectional study of cardiovascular disease and risk factors. Br Med J, 317, pp. 1125-1130.
41. Villar Ávarez F, Maiques Galán A, Brotons Cuixart C, Torcal Laguna J, Lorenzo Piqueres A, Vilaseca Canals J, et al. Prevención cardivoscular en atención primaria. Atención Primaria 2001;/28 Suppl 2:/23-36.
42. Wallis, EJ, Ramsay, LE, Haq, IU, Ghahramani, PRJ, Rowland-Yeo, K. and Yeo, WW. (2000) Coronary and cardiovascular risk estimation for primary prevention: Validation of a new Sheffield table in the 1995 Scottish health survey population. Br Med J, 320, pp. 671-676.
43. Wood, D., de Backer, G., Faergeman, O., Graham, I., Mancia, G. and Pyörälä, K. (1998) Prevention for coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J, 19, pp. 1434-1503.
44. Wood, D., Durrington, P., McInnes, G., Poulter, N., Rees, A. and Wray, R. (1998) Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart, 80, pp. 1-29.